SCHEMBL24569601

SCHEMBL24569601

CN1CC(/C=C2\CCN(C)C2=O)C1

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 1/20 0.33
▸ MEN1 O00255 1/20 0.30
▸ KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24570031 0.80 — —
SCHEMBL19757257 0.71 — —
SCHEMBL12374718 0.71 — —
SCHEMBL24570027 0.70 PIM1 (0.32) —
SCHEMBL12374763 0.63 MEN1 (0.37) MEN1KMT2A
SCHEMBL1339261 0.61 — —
SCHEMBL15254945 0.59 — —
SCHEMBL717518 0.59 BRD4 (0.43) MEN1KMT2A
SCHEMBL18745661 0.58 — —
SCHEMBL232823 0.57 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022140769-A1 LACTAM (HETERO)ARYLFUSEDPYRIMIDINE DERIVATIVES AS INHIBITORS OF ERBB2 ENLIVEN THERAPEUTICS, INC. (US) 2022-06-30 — — WO disclosed
Send feedback